NSW government seizes $1m of illegal e-cigarette products in 19 weeks

Events
Jun.13.2022

Cancer Council commends ‘zero tolerance’ for unlawful sales

 

Cancer Council NSW has commended the NSW Government’s “zero tolerance” of nicotine e-cigarette sales without a doctor’s prescription, following a major increase in the volume of illegal products seized in 2022 compared with the past two years.

 

Director of Cancer Prevention and Advocacy at Cancer Council NSW, Anita Dessaix, said the surge in illegal product seizures comes only six weeks after Australian National University (ANU) published a landmark study highlighting the extensive harms of e-cigarettes especially to young people.

 

“In the 18 months from July 2020 to the end of last year, $2 million worth of illegal nicotine e-cigarette products was seized – and the government has since seized half as much again in only 19 weeks this year,” Ms Dessaix said.

 

As it stands, the only legal way to access a vape containing nicotine is via a valid doctor’s prescription for those who feel it will aid their quit smoking journey. However, illegal seizure trends are growing exponentially,

 

“We see unlawful e-cigarette use everywhere we look, with young people the main users. Community concern among parents and teachers in particular is rising..

 

“The recently published ANU report showed that the majority of e-cigarette users are young, they are not using e-cigarettes to quit smoking, they are using e-cigarettes with, not instead of, tobacco and those who don’t smoke face a three-fold risk of smoking uptake.

“We congratulate the NSW Government for warning retailers selling e-cigarettes without a valid prescription that they could face fines and even jail for contributing to this crisis.

 

“For the sake of a profit, these merchants are addicting young people to nicotine, they are exposing young people to a three-fold risk of smoking uptake, and they are flouting federal and state laws designed to protect public health.

 

“NSW Government, and its Chief Health Officer, Dr Kerry Chant, have shown great leadership in highlighting the major harms of e-cigarettes and putting the merchants who are contributing to it on notice.”

 

“This is about ensuring that vaping doesn’t undo decades of public health efforts to prevent harm caused by tobacco products”.

Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
 NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.
News
May.21
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
China’s vape-related exports fell 10.25% year on year in May 2026, marking a second consecutive monthly decline, although exports recovered modestly from April. January-May exports totaled US$4.018 billion, down 0.86% from a year earlier and broadly in line with 2025 levels.
Special Report
Jun.29